Rezolute, Inc. (RZLT)
4.87
+0.23
(+4.96%)
USD |
NASDAQ |
Oct 09, 16:00
4.86
-0.01
(-0.21%)
After-Hours: 20:00
Rezolute Price to Book Value : 4.663 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.663 |
| October 08, 2026 | 4.443 |
| October 07, 2026 | 4.194 |
| October 06, 2026 | 4.136 |
| October 05, 2026 | 4.146 |
| October 02, 2026 | 3.840 |
| October 01, 2026 | 3.897 |
| September 30, 2026 | 3.964 |
| September 29, 2026 | 3.916 |
| September 28, 2026 | 4.002 |
| September 25, 2026 | 3.734 |
| September 24, 2026 | 3.772 |
| September 23, 2026 | 3.830 |
| September 22, 2026 | 3.868 |
| September 21, 2026 | 3.744 |
| September 18, 2026 | 3.677 |
| September 17, 2026 | 3.782 |
| September 16, 2026 | 3.811 |
| September 15, 2026 | 3.974 |
| September 14, 2026 | 4.069 |
| September 11, 2026 | 4.041 |
| September 10, 2026 | 3.993 |
| September 09, 2026 | 3.887 |
| September 08, 2026 | 4.213 |
| September 04, 2026 | 4.385 |
| Date | Value |
|---|---|
| September 03, 2026 | 4.347 |
| September 02, 2026 | 4.366 |
| September 01, 2026 | 4.309 |
| August 31, 2026 | 4.491 |
| August 28, 2026 | 4.424 |
| August 27, 2026 | 4.768 |
| August 26, 2026 | 4.826 |
| August 25, 2026 | 4.797 |
| August 24, 2026 | 4.797 |
| August 21, 2026 | 4.874 |
| August 20, 2026 | 4.462 |
| August 19, 2026 | 4.519 |
| August 18, 2026 | 4.462 |
| August 17, 2026 | 4.481 |
| August 14, 2026 | 4.404 |
| August 13, 2026 | 4.404 |
| August 12, 2026 | 4.500 |
| August 11, 2026 | 4.424 |
| August 10, 2026 | 4.481 |
| August 07, 2026 | 4.491 |
| August 06, 2026 | 4.500 |
| August 05, 2026 | 4.481 |
| August 04, 2026 | 4.759 |
| August 03, 2026 | 4.701 |
| July 31, 2026 | 4.519 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Avalo Therapeutics, Inc. | 1.609 |
| Opus Genetics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.98 |
Price to Book Value Related Metrics
| Price | 4.87 |
| Earnings Yield | -15.33% |
| Market Cap | 469.50M |